These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 23427371)

  • 1. Worms on the brain: fatal meningoencephalitis from disseminated strongyloides infection.
    Dokmeci O; Forshay B; Scholand SJ
    Conn Med; 2013 Jan; 77(1):31-3. PubMed ID: 23427371
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salvage treatment of disseminated strongyloidiasis in an immunocompromised patient: therapy success with subcutaneous ivermectin.
    Moura EB; Maia Mde O; Ghazi M; Amorim FF; Pinhati HM
    Braz J Infect Dis; 2012; 16(5):479-81. PubMed ID: 22975175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strongyloides stercoralis hyperinfection: difficulties in diagnosis and treatment.
    Feely NM; Waghorn DJ; Dexter T; Gallen I; Chiodini P
    Anaesthesia; 2010 Mar; 65(3):298-301. PubMed ID: 20003112
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous manifestations of Strongyloides stercoralis hyperinfection in an HIV-seropositive patient.
    Martin SJ; Cohen PR; MacFarlane DF; Grossman ME
    Skinmed; 2011; 9(3):199-202. PubMed ID: 21675505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Case report: failure of subcutaneous ivermectin in treating Strongyloides hyperinfection.
    Leung V; Al-Rawahi GN; Grant J; Fleckenstein L; Bowie W
    Am J Trop Med Hyg; 2008 Dec; 79(6):853-5. PubMed ID: 19052292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of human disseminated strongyloidiasis with a parenteral veterinary formulation of ivermectin.
    Marty FM; Lowry CM; Rodriguez M; Milner DA; Pieciak WS; Sinha A; Fleckenstein L; Baden LR
    Clin Infect Dis; 2005 Jul; 41(1):e5-8. PubMed ID: 15937753
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
    Turner SA; Maclean JD; Fleckenstein L; Greenaway C
    Am J Trop Med Hyg; 2005 Nov; 73(5):911-4. PubMed ID: 16282302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Subcutaneous ivermectin in disseminated strongyloidiasis: A veterinary preparation authorised for human use].
    Manrique-Rodríguez S; Martín-Rabadán P; Díaz-Cámara M; Fernández-Llamazares CM
    Med Clin (Barc); 2016 Apr; 146(8):376-7. PubMed ID: 26654554
    [No Abstract]   [Full Text] [Related]  

  • 9. Cutaneous manifestation of disseminated strongyloidiasis in a patient coinfected with HTLV-I.
    Arch EL; Schaefer JT; Dahiya A
    Dermatol Online J; 2008 Dec; 14(12):6. PubMed ID: 19265619
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Strongyloides hyperinfection syndrome complications: a case report and review of the literature.
    Najmuddin A; Hadique S; Parker J
    W V Med J; 2012; 108(1):32-8. PubMed ID: 25134190
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal change nephrotic syndrome in a patient with strongyloidiasis.
    Miyazaki M; Tamura M; Kabashima N; Serino R; Shibata T; Miyamoto T; Furuno Y; Nishio T; Ohara J; Sakurai T; Otsuji Y
    Clin Exp Nephrol; 2010 Aug; 14(4):367-71. PubMed ID: 20224878
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Strongyloides disseminated infection successfully treated with parenteral ivermectin: case report with drug concentration measurements and review of the literature.
    Donadello K; Cristallini S; Taccone FS; Lorent S; Vincent JL; de Backer D; Jacobs F
    Int J Antimicrob Agents; 2013 Dec; 42(6):580-3. PubMed ID: 24269075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prompt diagnosis and treatment of strongyloidiasis in a renal transplant patient.
    Briasoulis A; Psevdos G
    South Med J; 2011 Jan; 104(1):72-3. PubMed ID: 21119560
    [No Abstract]   [Full Text] [Related]  

  • 14. Pulmonary strongyloidiasis.
    Jayaprakash B; Sandhya S; Anithakumari K
    J Assoc Physicians India; 2009 Jul; 57():535-6. PubMed ID: 20329418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disseminated Strongyloides stercoralis infection with a cutaneous presentation in an immunosuppressed patient.
    Benvenuti F; Carrascosa JM; Boada A; Ferrandiz C
    Eur J Dermatol; 2009; 19(4):404-5. PubMed ID: 19467975
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissemination: the fatal risk for a missed diagnosis of Strongyloides stercoralis infection.
    Boscolo M; Bisoffi Z
    J Infect; 2007 Sep; 55(3):284-5. PubMed ID: 17368549
    [No Abstract]   [Full Text] [Related]  

  • 17. Acute strongyloidiasis in Italian tourists returning from Southeast Asia.
    Angheben A; Mistretta M; Gobbo M; Bonafini S; Iacovazzi T; Sepe A; Gobbi F; Marocco S; Rossanese A; Bisoffi Z
    J Travel Med; 2011; 18(2):138-40. PubMed ID: 21366799
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Fulminant strongyloidiasis successfully treated by subcutaneous ivermectin: an autopsy case].
    Takashima N; Yazawa S; Ishihara A; Sugimoto S; Shiomi K; Hiromatsu K; Nakazato M
    Rinsho Shinkeigaku; 2008 Jan; 48(1):30-5. PubMed ID: 18386629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strongyloides stercoralis: a rare cause of obstructive duodenal stenosis.
    Juchems MS; Niess JH; Leder G; Barth TF; Adler G; Brambs HJ; Wagner M
    Digestion; 2008; 77(3-4):141-4. PubMed ID: 18446028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of strongyloides hyperinfection syndrome: a rheumatological point of view.
    Santiago M; Leitão B
    Eur J Intern Med; 2009 Dec; 20(8):744-8. PubMed ID: 19892301
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.